(12506936), R. K., (10696501), D. A., (12506942), A. R. A., (17380426), S. A. A., & (832403), D. A. (2022). Cost-Effectiveness Analysis of Sacubitril/Valsartan for Reducing the Use of Implantable Cardioverter-Defibrillator (ICD) and the Risk of Death in ICD-Eligible Heart Failure Patients with Reduced Ejection Fraction.
Chicago Style (17th ed.) Citation(12506936), Rasha Kaddoura, Dina Abushanab (10696501), Abdul Rahman Arabi (12506942), Sumaya Alsaadi Alyafei (17380426), and Daoud Al-Badriyeh (832403). Cost-Effectiveness Analysis of Sacubitril/Valsartan for Reducing the Use of Implantable Cardioverter-Defibrillator (ICD) and the Risk of Death in ICD-Eligible Heart Failure Patients with Reduced Ejection Fraction. 2022.
MLA (9th ed.) Citation(12506936), Rasha Kaddoura, et al. Cost-Effectiveness Analysis of Sacubitril/Valsartan for Reducing the Use of Implantable Cardioverter-Defibrillator (ICD) and the Risk of Death in ICD-Eligible Heart Failure Patients with Reduced Ejection Fraction. 2022.